Inspire Investing LLC Has $675,000 Stock Holdings in HealthEquity, Inc. $HQY

Inspire Investing LLC cut its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 14.4% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,444 shares of the company’s stock after selling 1,085 shares during the period. Inspire Investing LLC’s holdings in HealthEquity were worth $675,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Wealth Enhancement Advisory Services LLC boosted its holdings in HealthEquity by 24.7% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 6,380 shares of the company’s stock worth $564,000 after purchasing an additional 1,265 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. boosted its holdings in HealthEquity by 7,983.6% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 24,655 shares of the company’s stock valued at $2,179,000 after acquiring an additional 24,350 shares during the period. GAMMA Investing LLC boosted its holdings in HealthEquity by 25.9% during the first quarter. GAMMA Investing LLC now owns 1,571 shares of the company’s stock valued at $139,000 after acquiring an additional 323 shares during the period. Price T Rowe Associates Inc. MD boosted its holdings in HealthEquity by 995.6% during the first quarter. Price T Rowe Associates Inc. MD now owns 639,345 shares of the company’s stock valued at $56,500,000 after acquiring an additional 580,988 shares during the period. Finally, WCM Investment Management LLC bought a new stake in HealthEquity during the first quarter valued at about $20,230,000. 99.55% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on HQY. Weiss Ratings restated a “hold (c+)” rating on shares of HealthEquity in a report on Wednesday, October 8th. Barrington Research restated an “outperform” rating and set a $125.00 price target on shares of HealthEquity in a report on Friday, August 29th. Royal Bank Of Canada upped their price target on shares of HealthEquity from $109.00 to $110.00 and gave the company an “outperform” rating in a report on Wednesday, September 3rd. Jefferies Financial Group upped their price target on shares of HealthEquity from $130.00 to $134.00 and gave the company a “buy” rating in a report on Wednesday, September 3rd. Finally, Raymond James Financial reiterated a “strong-buy” rating and issued a $120.00 target price (up previously from $115.00) on shares of HealthEquity in a research note on Tuesday, July 8th. One analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $121.31.

HealthEquity Stock Performance

NASDAQ:HQY opened at $90.54 on Monday. HealthEquity, Inc. has a 12-month low of $74.07 and a 12-month high of $116.65. The company has a quick ratio of 4.23, a current ratio of 4.23 and a debt-to-equity ratio of 0.47. The firm has a market capitalization of $7.80 billion, a PE ratio of 54.87, a price-to-earnings-growth ratio of 1.30 and a beta of 0.47. The firm has a 50-day moving average price of $91.62 and a 200 day moving average price of $93.90.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings results on Tuesday, September 2nd. The company reported $0.92 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.92. HealthEquity had a net margin of 11.49% and a return on equity of 12.04%. The firm had revenue of $325.80 million during the quarter, compared to analyst estimates of $320.68 million. HealthEquity has set its FY 2026 guidance at 3.740-3.91 EPS. Research analysts anticipate that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Insider Activity at HealthEquity

In other news, EVP Michael Henry Fiore sold 1,781 shares of the firm’s stock in a transaction that occurred on Tuesday, October 7th. The shares were sold at an average price of $88.21, for a total transaction of $157,102.01. Following the completion of the sale, the executive vice president owned 49,795 shares of the company’s stock, valued at approximately $4,392,416.95. This trade represents a 3.45% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Delano Ladd sold 6,000 shares of the firm’s stock in a transaction that occurred on Friday, September 19th. The stock was sold at an average price of $94.11, for a total transaction of $564,660.00. Following the sale, the executive vice president directly owned 79,456 shares of the company’s stock, valued at approximately $7,477,604.16. The trade was a 7.02% decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.50% of the company’s stock.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.